Medullary thymic epithelial cells (mTECs) play a critical role in thymic negative selection of autoreactive thymocytes, especially for thymocytes specific for peripheral tissue-restricted self-antigens (TRA). Deficiency in lymphotoxin b receptor (LTbR) is associated with peripheral tissue inflammation, but whether this is caused by defective negative selection has been unclear; the significance of the LTbR pathway for negative selection is evident in some models but not others. Here, we revisit the data and clarify the role of LTbR in mTEC development and function and thymic TRA expression. These processes are discussed as potential mechanisms for LTbR-mediated control of negative selection.
Medullary thymic epithelial cells (mTECs), Aire and thymic negative selection
Negative selection of autoreactive thymocytes is a central mechanism for establishing self-tolerance. During this process, self-antigens are presented mainly by medullary thymic epithelial cells (mTECs) and/or thymic dendritic cells (DCs) to developing thymocytes to induce apoptosis of thymocytes with a high-affinity T cell receptor (TCR) against self-antigens [1] [2] [3] [4] [5] [6] . Although it is easy to understand how autoreactive T cells against ubiquitous selfantigens are purged, it had been a mystery how the same mechanism might forestall autoimmunity against peripheral tissue-restricted self-antigens (TRAs). The explanation began to emerge by the demonstration that a myriad of genes classified as peripheral tissue-restrictive are also expressed in thymic epithelial cells, especially in mTECs [7, 8] .
The importance of mTECs and mTEC TRA expression in the establishment of central tolerance is demonstrated mainly by the following two aspects. Firstly, abnormal mTEC development and organization is often associated with autoimmunity. Examples include Relb -/-mice [9, 10] , aly/aly mice [11] , Ikka -/-embryonic-thymi-grafted nude mice [12] , Traf6 -/-mice [13] , Nfkb2 -/-mice [14, 15] , Ltbr -/-mice [16] and Nfkb2 -/-Bcl3 -/-mice [17] . All these mice have disorganized or reduced cellularity of mTECs to different degrees; they also possess autoantibody and/or peripheral organ lymphocyte infiltration, the prototypical phenotype of autoimmunity. Additional evidence underlying the importance of organized mTECs in preventing autoimmunity is that in several autoimmune models, the disruption of thymic medulla (e.g. reduced mTECs, aberrant mTECs location in cortex) is often associated with, or precedes, the development of autoimmunity [18, 19] .
Secondly, genetically altered mice with reduced TRA thymic expression develop autoimmunity. A typical case is the autoimmune regulator (Aire) deficient mouse. The AIRE gene was first identified and cloned from patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome (APECED) [20, 21] . A subsequent study in mice revealed that Aire is a master regulator of ectopic expression of a large number of peripherally expressed genes in the thymus, and that Aire deficiency in mice leads to autoimmunity against peripheral organs [22] . This was initially attributed solely to reduced ectopic expression of thymic TRA [22, 23] . However, it was later found that Aire might possess roles other than regulation of TRA expression, such as regulation of antigen processing and presentation, mTEC differentiation and thymocyte migration [24] [25] [26] [27] [28] . Thus, the relative contribution of each Aire-related mechanism in mediating negative selection needs to be fully unraveled. Even so, a critical role for TRA expression in mTECs was demonstrated recently; investigators found that lack of a single protein, interphotoreceptor retinoid-binding protein (IRBP) in the thymus, even in the presence of Aire, is sufficient to trigger spontaneous eye-specific autoimmunity as found in Aire-deficient mice [29] .
Given the critical roles of mTECs and thymic TRA expression in negative selection, their regulation has been actively investigated. In this area of research, the lymphotoxin b receptor (LTbR) has received much attention given its important, yet complicated, role in thymic negative selection. Here, we attempt to revisit the data and clarify the controversial role of LTbR in mTEC development and function and in thymic TRA expression.
Can the LTbR pathway control negative selection of TRA-reactive T cells? LTbR belongs to the TNFR superfamily and is expressed extensively on stromal cells as well as DCs and macrophages, but not on T or B cells. Two ligands of LTbR have been identified so far: lymphotoxin (LT) and LIGHT. LT is expressed mainly on B, T and NK cells, while LIGHT is expressed on immature DCs, activated T cells and NK cells. The LTbR pathway plays a critical role in secondary lymphoid organ development and function [30, 31] . LTbR deficiency is associated with increased numbers of lymphocytes in peripheral organs, which when first described was presumed to be due to the lack of lymph nodes (LNs) in these mice [32] . However, further careful studies by two groups challenged this view with data showing lymphocyte infiltration in peripheral organs was independent of defective LNs and instead dependent on thymic defects [16, 32, 33] . This opened a new line of investigation into the control of T cell negative selection by LTbR. So far, four antigen-specific TCR transgenic and neo-self Ag transgenic systems have been employed to address the role of LTbR in thymic negative selection: (1) OT-I/RIP-mOVA, (2) OT-II/ RIP-mOVA, (3) TAG-I/TRAMP and (4) TGB/TRAMP (Box 1). Intriguingly, the results obtained from these different studies are somewhat divergent. In a study using the OT-II/RIP-mOVA system, LTbR had little influence on thymic negative selection [34] . However, in other studies using three different CD8 + transgenic TCR systems ( (1), (3) and (4) above), a significant role of LTbR on thymic negative selection was revealed [14, 35] . These different results, as well as a controversial role for LTbR in the control of TRA and Aire expression, have led to some confusion in the field regarding the role of LTbR in negative selection of TRAspecific T cells. This might be due to the different models used in the respective studies, such as CD4 versus CD8 T cells (DCs are believed to be the prime antigen-presenting cells (APCs) for CD4 T cells, whereas mTECs are thought to be the prime APCs for CD8 T cells [36] ) as well as analysis of different TRAs (with different promoters and mechanisms of regulation) for induction of thymic negative selection. More antigens and more models are needed to resolve this issue.
Can the LTbR pathway control mTEC development and organization? mTEC development is generally considered to be a stepwise process, where mTEC subsets are defined depending on their maturation status (represented by MHC-II or CD80 expression) and Aire expression (CD80   low   Aire   -,  CD80 high Aire -, CD80 high Aire + ) [37] . Different subsets of mTECs are presumed to have different TRA expression patterns and antigen presentation functions as well as different rates of turnover [8, [38] [39] [40] .
The role of the LTbR pathway in the thymus has been largely overlooked compared with its well defined role in peripheral lymphoid organogenesis and development [30, 41] . This was partially due to the grossly normal size and architecture of thymi from LT and LTbR deficient mice. However, in a study that examined the thymic medulla from Ltbr -/-mice in more detail, reduced numbers of mTEC subsets expressing UEA-1 and the non-polymorphic MHC-II antigen I-O were observed [16] . When defined as CD45 + G8.8 + CDR1 + B7.1 + , the total number of mTECs was also dramatically reduced in Ltbr -/-thymi. LTb deficiency was found to have a non-identical phenotype in this regard. In fact, when studying LTbR ligands, it was found that in LTb and LIGHT double-deficient mice, in which both known ligands of LTbR are ablated, the thymic phenotype found in Ltbr -/-mice was only partially reproduced. Thus it was hypothesized that additional unknown ligand(s) of LTbR exist. A role for the LTbR pathway in mTEC development was observed by two other groups [34, 42] , and the milder effect of LTa deficiency, compared with LTbR, on mTEC development was also noted [34] . Furthermore, the development of the Aire + MHC-II high mTEC population was also found to be dependent on LTbR [34, 42] . It is now generally agreed that LTbR is required for proper mTEC development. It remains unclear, however, exactly how, and at which differentiation stage, LTbR regulates mTEC development (Box 2).
It must be noted that other TNFR superfamily members, CD40 and RANK, are also important for mTEC development and central tolerance [43] [44] [45] . This is not surprising, as both CD40 and RANK can deliver signals through the non-canonical NF-kB pathway. However, it is surprising that so many TNFR family members are involved in mTEC development. This coordinated regulation pattern of mTECs by different molecules is probably based on different ligand-receptor spatial and temporal expression patterns [46] , which highlights the fact that the finely tuned regulation of mTECs is crucial for establishing central tolerance.
It is important to note the LTbR pathway is also involved in mTEC organization. In immunofluoresence microscopy experiments not all mTEC markers reveal identical defects in thymic medulla organization; obvious disorganization is detected using UEA-1 staining but is less clear with MTS-10 staining [16, 32] . Lectin UEA-1-expressing mTECs were found in clumps, and the connective mTEC network was disrupted in mice with LTbR deficiency [16] , when compared with the broad and even distribution in wild type (WT) thymi. A similar finding was noted in Nfkb2 -/-, plt/plt and Ccr7 -/-mice [47, 48] . Thymocyte migration in the thymus is a highly organized process and the developing thymocytes need to patrol the thymic medulla for antigen to undergo negative selection [49, 50] . Whether disrupted mTECs/medulla organization itself also influences negative selection of autoreactive thymocytes remains largely unclear and awaits further investigation. , respectively. RIP-mOVA transgenic mice bear membrane-bound ovalbumin under the control of the rat insulin 1 promoter. TRAMP mice bear SV40-T antigen under the control of the probasin promoter. Both insulin 1 and probasin are considered to be TRAs. Thus, mOVA and SV40-Tag driven by these promoters are considered to be expressed in a way that mimics TRA expression. 9 normal Aire expression was found in mTECs isolated from Ltbr -/-thymi by semiquantitative RT-PCR [16] . Supporting the latter, normal Aire and TRA expression in Lta -/-thymi was found by semiquantitative PCR and Lta -/-thymi showed largely normal Aire + mTEC frequency by tissue immunofluoresence staining [11, 51] . Thus, these studies led to the suggestion that the LT-LTbR pathway regulates Aire and TRA expression in thymus through indirect mechanisms.
Opinion
More recent studies have attempted to clarify this controversial issue by analyzing Aire and TRA gene expression in more detail on a per cell basis [34, 52] . In these studies, purified mTECs from Ltbr -/-and/or Lta -/-mice showed no reduction of Aire or TRA gene expression when compared with WT mTECs using both gene array and quantitative RT-PCR. Thus, these studies concluded that LTbR signaling is not directly required for TRA expression in mTECs. Instead, based on gene profiling, it was proposed that the role of LTbR on Aire expression might not be direct but indirect through the regulation of mTEC development [34, 52] . The data suggest that the reduction of Aire or TRA in whole thymic tissues seen in earlier studies is likely to be associated with the reduced number of total or subsets of mTECs rather than reduced Aire expression in individual cells.
To study this further, MHC-II hi (mature) and MHC-II lo (immature) mTECs were isolated, from Lta -/-and Ltb -/-mice and Aire and TRA expression was measured. While Aire expression was not reduced in either subset of mTECs from Lta -/-or Ltb -/-mice compared with WT, some Airedependent (including insulin 2) and Aire-independent TRAs were reduced in both the Lta -/-and Ltb -/-mTEC subsets [42] . This supports a direct role for LT signaling in regulating expression of some TRAs in mTECs. It is worth noting that this study also found that LT deficiency has a much more pronounced effect on TRA expression in the MHC-II lo mTEC subset than in the MHC-II hi mTEC subset, which raises the possibility that LT signaling might be more important for TRA expression in some mTEC subsets than others [42] .
The studies described above focused mostly on the essential role of the LT-LTbR pathway in Aire and TRA expression. Whether the LTbR signaling pathway is sufficient to upregulate Aire and TRA expression is a different question. Efforts to address this issue have been somewhat limited due to the lack of appropriate reagents and the lowlevel expression of antigens in mTECs. However, an earlier study showed that treatment of mice with the 3C8 clone of agonistic anti-LTbR upregulated in vivo thymic Aire, Insulin 1 and Collagen II transcript expression after several hours [32, 33] . Furthermore, in vitro experiments showed that 3C8 treatment of the mTEC cell line 427.1 can upregulate the expression of these genes, suggesting a direct impact of LTbR signaling on Aire and TRA expression in mTECs [32] . However, upregulation of Aire by agonisitic LTbR antibody was not found in a recent study using a 2-deoxyglucose (2-DG)-treated fetal thymic organ culture (FTOC) while Crp (an Aire-independent TRA) was significantly upregulated [45] . Thus, different conclusions have been drawn from these two studies. It should be kept in mind that different models, reagents and stimulation time were used in these studies and the role of LT-LTbR might be different in different scenarios.
It is worth noting several issues when interpreting the data described above. Firstly, the induction or upregulation of Aire and TRA expression by direct LTbR signaling raises the interesting question of whether TRA-specific TCR-pMHC interactions during thymocyte development feed back on mTECs to upregulate TRA via stabilized LTLTbR signaling on an individual cell basis. Given the rare interaction events between TRA-specific TCR and TRA presented by mTECs, this crosstalk between individual thymocytes and mTECs, mediated by an LT-LTbR interaction, might help to increase the efficiency of negative selection. Secondly, it is possible that LTbR plays a more essential role in certain subsets of mTECs than in others [42] . This effect could be compromised when the whole mTEC population is analyzed instead of mTEC subsets [34, 52] . Thirdly, LTbR appears to be essential for the expression of only a subset of TRAs. Several other TNF family members, similar to LTbR, are essential for mTEC development [43] [44] [45] . Do they also control TRA expression directly? If yes, how do they cooperate with LTbR? These are interesting questions that should be answered by future work. Last, but not least, one can argue that agonistic antibodies that regulate TRA expression might provide means for clinical intervention to enhance negative selection thus providing better central tolerance. However, the clinical relevance of 'sufficiency' for TRA expression and the amount of TRA upregulation required for tolerance induction are not known.
As discussed in the previous section, it is clear that LTbR plays an essential role in mTEC development/organization [14] [15] [16] 34, 52] and by doing so the LTbR pathway can control thymic TRA expression indirectly. Thus, although the direct role of LT-LTbR signaling on Aire expression could be limited at steady state, LT-LTbR signaling would indirectly induce Aire to control negative selection by regulating the development and organization of mTECs.
Could the LTbR pathway regulate thymocyte migration?
We have unexpectedly identified another role for LTbR in central tolerance; that is, regulation of mTEC chemokine expression and thymocyte migration [14] . This study originated from an unexpected finding in the OT-I/RIPmOVA system used to address the role of LTbR in thymic negative selection. Although thymic mOVA expression remains normal in RIP-mOVAtg/Ltbr -/-mice, we still found defective thymic negative selection of OT-I cells when LTbR was deficient. This finding, together with previous data showing that LTbR controls chemokine expression in peripheral tissues, and the important role of chemokines in central tolerance, led us to examine whether LTbR controls chemokine expression in the thymus, thereby altering migration of developing thymocytes. Indeed, we found impaired secondary lymphoid organ chemokine (SLC) and EBI1-ligand chemokine (ELC) expression in mTECs from Ltbr -/-mice, which resulted in defective thymocyte migration to the medulla. To further evaluate the role of the SLC and ELC defect itself on thymic negative selection, we used plt/plt mice, in which SLC and ELC are both deficient, and found that SLC and ELC deficiency alone is sufficient to lead to a thymic negative selection defect and these findings have been confirmed by others [42, 48] .
Implications of LTbR-regulated negative selection
Although the underlying mechanisms are not fully understood, the role of LTbR on negative selection of TRAreactive T cells is clear, at least for certain TRA-reactive T cells. Given the significant influence of LTbR on negative selection of TRA-reactive CD8 + T cells and the fact that many tumors express organ-restricted self-antigens, a recent study creatively applied this knowledge to the prevention of tumor development [35] . In this study, ablation of LT signaling either by LTa deficiency, or by administering an LTbR-human Ig fusion protein, dramatically rescued most high-affinity tumor/self-specific TCR clones, which was associated with inhibited/reduced spontaneous tumor development in the TRAMP prostate cancer model. This study reveals a significant role for the LTbR pathway in negative selection and, together with other studies as discussed above, suggests that the degree of LTbR involvement in thymic negative selection might depend on the type of TRA and/ or the type of promoter regulating the TRA, as well as the mTEC subsets involved. In fact, LTbR signaling ablation showed a more dramatic rescue in the TAG-I-TRAMP system than that in the OT-I-RIP-mOVA system (20-fold versus 3-fold). There are at least three models that could explain these data: (1) RIP-driven mOVA and probasin promoter-driven SV40-Tag are expressed in different subsets of mTECs; (2) the transcription or translation of the two genes is regulated differentially by LTbR; and (3) the affinity of the antigenic epitopes of the two proteins to TCR is different. Those models remain to be tested in future work.
It is worth noting that blocking the LTbR pathway could have multiple effects in addition to rescue of high-affinity TRA-reactive T cells. Several models have shown blockade of the LTbR pathway reduces inflammation [53] [54] [55] , and inflammation has been considered a factor in promoting cancer development [56] . Additionally, the LTbR pathway was found to promote tumor growth by inducing angiogenesis [57] . A recent study demonstrated that the LTbR Figure 1 . Direct and indirect roles of LTbR in mTEC development and function. LTbR signaling regulates mTEC development and function in various ways. LTbR controls mTEC differentiation; however, it is not known at which stage or how LTbR controls this process. LTbR is not essential for Aire thymic expression but is indeed essential for expression of some Aire-dependent and Aire-independent TRA on a per cell basis. In addition, LTbR might have more impact on TRA expression in some subsets of mTECs than others. The underlying molecular mechanism remains to be determined. LTbR signaling also controls mTEC organization and chemokine production, which might indirectly regulate thymocyte migration or TRA expression and presentation to developing thymocytes. It is unclear which cells deliver which ligand(s) to LTbR for control of mTEC differentiation, TRA and chemokine expression; LT appears to play only a partial role. It is also intriguing to ask whether TCR-pMHC interaction between thymocytes and mTECs is required for LTbR to fulfill its roles.
Opinion
Trends in Immunology Vol. 31 No.9 signaling pathway is upregulated in chronic HBV or HCV infection-induced hepatitis and hepatocellular carcinoma [58] . Thus, it cannot be excluded that additional mechanisms contributed to tumor prevention.
Concluding remarks
The studies on the role of LTbR in thymic negative selection have raised interesting new questions about how T cells are negatively selected and how LTbR signaling is required for the control of negative selection of some TRAreactive T cells, but not others. Earlier studies helped clarify the complicated roles of LTbR in various aspects of thymic negative selection ( Figure 1 ). As discussed above, while evaluating the role of LTbR in negative selection, it is worthwhile considering the experimental model and methods used to modulate LTbR signaling (Table 1) . Thus, it is not surprising that the role of LTbR in thymic negative selection of TRA-specific T cells is revealed in some studies but not in others. The different results obtained under different scenarios underscore the complicated regulation of thymic negative selection and help to suggest future research directions in which to discover novel factors in this important thymic process. Some key questions that should be addressed in future work are outlined in Box 2. Increased understanding of the mTEC differentiation program, the role of LTbR and, more broadly, all TNFR superfamily receptors, will help us to have a more comprehensive overview of thymic negative selection of various TRA-specific T cells. Furthermore, we can expect to see more preclinical studies using techniques designed to regulate negative selection for the combat of cancer and autoimmune disease. 
